Side effects include:
Transient bradycardia, oxygen desaturation, endotracheal tube reflux, pallor, vasoconstriction, hypotension, endotracheal tube blockage, hypertension, hypocarbia, hypercarbia, apnea.

The most commonly reported adverse experiences were associated with the dosing procedure; transient bradycardia occurred with 11.
9% of doses and oxygen desaturation occurred with 9.
8% of doses.
Very common (10% or more): Transient bradycardia (11.
9%)Uncommon (0.
1% to 1%): Pallor, vasoconstriction, hypotension, hypertension, hypercarbia, hypocarbiaFrequency not reported: Tachycardia, ventricular tachycardia, aortic thrombosis, cardiac failure, cardio-respiratory arrest, increased apical pulse, persistent fetal circulation, air embolism, total anomalous pulmonary venous return
Common (1% to 10%): Oxygen desaturationUncommon (0.
1% to 1%): ApneaFrequency not reported: Lung consolidation, blood from the endotracheal tube, deterioration after weaning, respiratory decompensation, subglottic stenosis, paralyzed diaphragm, respiratory failure
Uncommon (0.
1% to 1%): Endotracheal tube reflux, endotracheal tube blockageFrequency not reported: Abdominal distension, hemorrhage, intestinal perforations, volvulus, bowel infarct, feeding intolerance, stress ulcer
Frequency not reported: Adrenal hemorrhage, inappropriate ADH secretion, hyperphosphatemia
Frequency not reported: Coagulopathy, thrombocytopenia, disseminated intravascular coagulation
Frequency not reported: Hepatic failure
Frequency not reported: Inguinal hernia
Frequency not reported: Seizures
Frequency not reported: Renal failure, hematuria
It is possible that some side effects of Survanta may not have been reported.
These can be reported to the FDA here.
Always consult a healthcare professional for medical advice.